Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

KPMG Speaks On What 2022 Medtech Investment May Look Like

Feb 15 2022

• By Barnaby Pickering

Alamy

Related Content

Shortsellers Say Gingko BioWorks Is ‘Colossal Synthetic Biology Scam'

Oct 07 2021

Pandemic Perspectives: A Lasting Impact On Medtech, But Not Dealmaking

Mar 12 2021

Hologic Continues Spending Spree With $230M Tuck-In Acquisition Of Biotheranostics

Jan 06 2021

Related Companies

Hologic, Inc.

Additional Topics

Digital Health Financing M & A Deals Commercial Medical Device

More from Digital Technologies

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window